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Abstract 
Background: Severe malaria has a case fatality rate of 10‑20 %; however, few studies have addressed the quality of 
severe malaria case management. This study evaluated the diagnostic and treatment practices of malaria patients 
admitted to inpatient health facilities (HF) in Malawi.
Methods: In July–August 2012, a nationwide, cross‑sectional survey of severe malaria management was conducted 
in 36 HFs selected with equal probability from all eligible public sector HFs in Malawi. Patient records from all admis‑
sions during October 2011 and April 2012 (low and high season, respectively) were screened for an admission diagno‑
sis of malaria or prescription of any anti‑malarial. Eligible records were stratified by age (< 5 or ≥ 5 years). A maximum 
of eight records was randomly selected within each age and month stratum. Severe malaria was defined by admis‑
sion diagnosis or documentation of at least one sign or symptom of severe malaria. Treatment with intravenous (IV) 
quinine or artesunate was considered correct. Patients without documentation of severe malaria were analysed as 
uncomplicated malaria patients; treatment with an artemisinin‑based combination therapy (ACT) or oral quinine 
based on malaria test results was considered correct. All analyses accounted for HF level clustering and sampling 
weights.
Results: The analysis included 906 records from 35 HFs. Among these, 42 % (95 % confidence interval [CI] 35–49) had 
a severe malaria admission diagnosis and 50 % (95 % CI 44–57) had at least one severe malaria sign or symptom docu‑
mented. Severe malaria patients defined by admission diagnosis (93, 95 % CI 86–99) were more likely to be treated 
correctly compared to patients defined by a severe sign (82, 95 % CI 75–89) (p < 0.0001). Among uncomplicated 
malaria patients, 26 % (95 % CI 18–35) were correctly treated and 53 % (95 % CI 42–64) were adequately treated with 
IV quinine alone or in combination with an ACT or oral quinine.
Conclusions: A majority of patients diagnosed with severe malaria received the recommended IV therapy in accord‑
ance with national treatment guidelines. However, the inconsistencies between diagnosis of severe malaria and 
documentation of severe signs and symptoms highlight the need to improve healthcare worker recognition and 
documentation of severe signs and symptoms.
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Background
Despite the availability of effective interventions for the 
prevention and treatment of uncomplicated malaria, the 
burden of severe malaria remains considerable. In 2014, 
malaria was responsible for an estimated 438,000 deaths 
worldwide, with a majority of deaths occurring in sub-
Saharan Africa and in children under 5 years of age [1]. 
Young children in areas of stable transmission are at 
increased risk of progression to severe disease compared 
to adults [2] and more frequently present with impaired 
consciousness, respiratory distress, multiple convulsions, 
severe anaemia, hypoglycaemia, acidosis, hyperlactatae-
mia, and hyperparasitaemia [2–4]. Among hospitalized 
patients under 5  years of age, the case fatality rate for 
severe malaria is estimated to be between 10–20 % [4–6]. 
Prompt care is essential as most deaths occur within the 
first 24 h of hospital admission [7].
Optimal case management of severe malaria is 
complex and requires prompt recognition of clinical 
manifestations of severe malaria, initiation of appro-
priate treatment, monitoring of disease progression, 
and management of co-morbidities. These processes 
also rely on the availability of health system resources 
such as diagnostic and treatment supplies. Given that 
effective case management of severe malaria is multi-
faceted, few studies have sought to evaluate the qual-
ity of patient care in sub-Saharan Africa. In Uganda, a 
2009 health facility survey of severe malaria case man-
agement practices found that, of all patients assessed, 
only 27 % were correctly diagnosed with severe malaria 
and 30  % did not receive the correct initial parenteral 
anti-malarial at the appropriate dose and frequency. 
Although 54  % of facilities reported no stock-outs of 
the recommended parenteral quinine in the 3  months 
prior to the survey, no facilities had consistent avail-
ability of all supplies required for the management of 
severe malaria [8].
Malaria is a leading cause of hospital admissions and 
hospital deaths in Malawi and places considerable stress 
on the health system. In 2010, malaria was responsible 
for 40  % of all hospital admissions in children under 
5 years of age, 34 % of all outpatient visits, and an esti-
mated 40 % of all hospital deaths [9]. These challenges 
and the burden of severe malaria in Malawi underscore 
the need to assess severe malaria case management 
practices.
The objective of this survey was to better understand 
how severe malaria is currently managed at public inpa-
tient health facilities in Malawi. Specifically, the qual-
ity of care given to severe malaria patients admitted to 
inpatient health facilities with respect to the 2011 Malawi 




Malaria is endemic and occurs year-round in Malawi, 
with peak transmission during the rainy season from 
November to April. Malaria infections are predominantly 
caused by Plasmodium falciparum and the national par-
asite prevalence among children under 5 years of age in 
2012 was estimated to be 28 % by microscopy and 43 % 
by rapid diagnostic test (RDT) [11].
In Malawi, primary care services including the man-
agement of uncomplicated malaria are available at health 
centers, community hospitals, and district hospitals. Sec-
ondary care services, including management of severe 
malaria, are provided at community or district hospitals. 
Publicly funded health facilities are managed by either 
the government, which provides care at no cost, or the 
Christian Health Association of Malawi (CHAM), which 
requires a small fee for services [12].
According to the Malawi Revised Guide for the Man-
agement of Malaria, released in 2011, severe malaria is 
diagnosed based on the presence of one or more severe 
clinical or laboratory findings. Although parasite con-
firmation by microscopy is recommended, parenteral 
treatment with either quinine or artesunate should be 
initiated immediately if severe malaria is suspected. 
For uncomplicated malaria, the guidelines recommend 
laboratory confirmation by RDT or microscopy prior to 
treatment initiation, and administration of artemether-
lumefantrine (AL) as first-line or artesunate-amodi-
aquine as second-line treatment for confirmed cases.
Study design
In July–August 2012, a nationwide, cross-sectional sur-
vey of inpatient malaria case management was conducted 
in 36 health facilities systematically selected with equal 
probability from a list of all public sector health facilities 
in Malawi that admit patients with malaria. Health facili-
ties were ordered by region (north, central, and south), 
managing authority (government and CHAM) and hos-
pital type (district, community, or other) prior to system-
atic random selection. In the selected facilities, survey 
teams conducted interviews of patients admitted for 
severe malaria, interviews of healthcare workers to assess 
knowledge, training, and supervision, an evaluation of 
health facility supplies and capacity, and retrospective 
reviews of health records of previously admitted patients. 
The methodology and results from the retrospective 
reviews of patient health records are described here.
Sampling of patient records and sample size determination
Records from all patients admitted to medical wards, 
pediatric wards or intensive care units during October 
2011 (low malaria season) and April 2012 (high malaria 
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season) were screened for an admission diagnosis of 
malaria or prescription of any anti-malarial drug. Eligible 
records meeting these criteria were then stratified by age 
(<5 and ≥5 years). A maximum of eight patient records 
was randomly selected within each age group and month 
stratum for a total of up to 32 records per health facility.
The sample size was estimated based on a conservative 
outcome proportion of 50 %, design effect of 1.8, preci-
sion of ±10 %, and type I error of 5 %, resulting in 269 
records per stratum or 1076 in total. After adjustment for 
a potential loss of 10 % due to missing records, the final 
required sample size was determined to be eight patient 
records per stratum.
Data management and analysis
Patient records were abstracted by medically trained sur-
veyors on a standardized form. The abstracted forms were 
electronically entered independently by two data entry 
clerks and all discrepancies were resolved by consulting 
the data abstraction forms. The two definitions of severe 
malaria described below were analysed as separate out-
comes. Estimations of proportions and 95  % confidence 
intervals (CIs) were calculated using survey procedures in 
SAS version 9.3 (SAS Institute Inc., Cary, NC) to account 
for clustering at the health facility level and weighted by 
the inverse of the probability of selection. Results were 
stratified by age (<5 and ≥5 years), region, health facility 
managing authority, and month of admission. Rao–Scott 
Chi Square was used to test for differences between cat-
egorical variables. Risk ratios (RRs) were estimated using 
a log-binomial regression model with a generalized esti-
mating equations approach to account for correlation 
from repeated measures within the same health facility. 
The populations of severe malaria patients defined based 
on admission diagnosis and the population defined based 
on documentation of a severe sign were not independ-
ent and, therefore, comparisons between the proportions 
of severe malaria patients correctly treated by each defi-
nition were made by accounting for repeated measures 




Severe malaria was defined and analysed in two ways:
1. By admission diagnosis of severe malaria, cerebral 
malaria, or severe anaemia as documented by the 
healthcare worker.
2. By documentation of at least one sign of severe 
malaria, including any of the following: seizures, 
lethargy, coma, vomiting everything, unable to eat, 
jaundice, difficulty breathing, difficulty urinating, red 
urine, easy bleeding/bruising, abnormal mental sta-
tus, abnormal neurologic exam, or severe anaemia 
(haemoglobin level <5 grams per decilitre).
Patients who were admitted for malaria or who 
received an anti-malarial, and did not meet either of the 
above criteria for severe malaria were considered to have 




  • Correct treatment was defined as treatment with 
either intravenous (IV) quinine or IV artesunate.
  • Under-treatment was defined as treatment with no 
or ineffective anti-malarial treatment.
Uncomplicated malaria
  • Correct treatment was defined as treatment exclu-
sively with an artemisinin-based combination ther-
apy (ACT) or oral quinine among laboratory-con-
firmed or clinically diagnosed uncomplicated malaria 
patients (Fig. 1).
  • Adequate treatment was defined as treatment with 
an IV anti-malarial (considered clinically effective, 
but not in line with recommended national guide-
lines) among laboratory-confirmed or clinically diag-
nosed uncomplicated malaria patients (Fig. 1).
  • Under-treatment was defined as no or ineffective 
anti-malarial treatment among laboratory-con-
firmed or clinically diagnosed uncomplicated malaria 
patients (Fig. 1).
  • Over-treatment was defined as treatment with an IV 
anti-malarial, ACT, or oral quinine among patients 
without documentation of a sign or admission diag-
nosis of severe malaria with a negative laboratory 
result (Fig. 1).
Results
Among the 36 health facilities surveyed, 4982 patient 
records were screened for inclusion from October 2011 
and April 2012. Fever was documented in 53  % of all 
patient records, of which, 77 % were eligible for inclusion. 
Approximately half (52 %) of patient records screened had 
an admission diagnosis of malaria or prescription of an 
anti-malarial. No records were available at one of the sam-
pled health facilities and only two facilities had sufficient 
eligible patient records in all four strata to reach the target 
sample size. Of the remaining facilities, seven had at least 
seven records per stratum, 11 had at least six records per 
stratum, nine had at least five records per stratum, and six 
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had between one and four records per stratum. At facili-
ties with an insufficient number of patient records, all eli-
gible records were abstracted and analysed. A total of 906 
patient records with complete data across 35 health facili-
ties were included in this analysis (Fig. 2).
Characteristics of patients analysed
Patients were between 3 months and 81 years of age and 
approximately half (52  %) were female. Although most 
patients were febrile at the time of admission, patients 
<5  years were more likely to present with fever (94  %) 
than patients ≥5  years (79  %) (p  <  0.0001). Laboratory 
testing for malaria was performed for 67  % of patients 
overall (70  % in children <5  years vs. 61  % in patients 
≥5  years, p  =  0.04) and microscopy was performed in 
56  % of all patients tested for malaria, with no signifi-
cant difference by age. Laboratory-confirmed malaria 
was significantly higher in children <5 years compared to 
patients ≥5 years (53 vs. 37 %, respectively; p < 0.0001) 
and in patients admitted in April 2012 (high malaria 
season) compared to October 2011 (low season) (55 vs. 
35  %, respectively; p  <  0.0001). A majority of patients 
(>90 %) were discharged alive and well, while the remain-
ing patients were either discharged with morbidity or 
died during admission (Table 1).
Diagnosis of severe malaria
The most common admission diagnosis was unspeci-
fied malaria (51  %), followed by severe malaria (40  %). 
Uncomplicated malaria was diagnosed in 2 % of patients, 
severe anaemia was diagnosed in 2  % and cerebral 
malaria was diagnosed in <1  % (Table  2). Overall, 42  % 
(95  % confidence interval [CI] 35–49) of patients had a 
severe malaria admission diagnosis (including diagnosis 
of severe malaria, cerebral malaria, or severe anaemia). 
An admission diagnosis of severe malaria was signifi-
cantly more likely in April 2012 (high season, 48 %) than 
in October 2011 (low season, 35 %) (p = 0.0006), in gov-
ernment facilities (52 %) than in CHAM facilities (35 %) 
(p = 0.0008) and in children <5 years (48 %) compared to 
patients ≥5 years (34 %) (p = 0.002). No significant dif-
ferences in admission diagnoses were observed by region.
Half (50, 95  % CI 44–57) of patients had at least one 
severe malaria sign or symptom documented. Overall, 
the most commonly documented severe symptoms were 
seizures (20  %), lethargy/coma (15  %), difficulty breath-
ing (9 %), and severe anaemia (7 %). Severe anaemia was 
higher among patients admitted in government facilities 
(10 %) compared to CHAM facilities (5 %) (p = 0.04) and 
in children <5 years (10 %) compared to patients ≥5 years 
(4 %) (p = 0.0004). In addition, in children <5 years, sei-
zures (24  %), jaundice (3  %), and difficulty breathing 
(12 %) were significantly more common than in patients 
≥5 years (p < 0.03) (Table 3). However, children <5 years 
had a similar risk for any severe sign/symptom as patients 
≥5 years (RR = 1.3, 95 % CI 1.0–1.8) and no significant 
differences by region, health facility, and month of admis-
sion were observed.
Uncomplicated malaria 
(no documented sign or admission diagnosis of severe malaria)
Lab negative No result or not tested
Exclusively an 
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Fig. 1 Treatment definitions for uncomplicated malaria patients. ACT artemisinin‑based combination therapy; IV intravenous
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Of the 40  % of patients admitted with a diagnosis of 
severe malaria, 59  % also had a documented sign of 
severe disease (shown in blue, Fig. 3). In addition, almost 
half (44 %) of patients without an admission diagnosis of 
severe malaria had documentation of a severe sign. Thus, 
only 49 % of those with a documented sign of severe dis-
ease were diagnosed with severe malaria at admission 
(shown in red, Fig. 3). Overall, 25 % of patients had severe 
malaria both by admission diagnosis and by documenta-
tion of a severe sign (shown in purple, Fig. 3). Given that 
approximately half of patients could be misclassified by 
using one definition alone or many patients would be 
misclassified by restricting to those meeting the criteria 
for both definitions, severe malaria diagnosis by docu-
mentation of severe sign and by admission diagnosis 
were analysed separately.
Treatment of severe malaria patients
Overall, 85  % (95  % CI 79–91) of all severe malaria 
patients, either defined by admission diagnosis or by 
sign of severe disease were treated correctly with rec-
ommended IV therapy. Among all ages, significantly 
more severe malaria patients by admission diagnosis 
(93, 95  % CI 86–99) were correctly treated compared 
to patients defined by severe sign (82, 95  % CI 75–89) 
(p < 0.0001). The proportion of severe malaria patients 
correctly treated did not differ significantly by age for 
either definition of severe disease. All severe malaria 
patients that were treated with an IV anti-malarial 
received quinine. The remaining severe malaria patients 
received either exclusively an ACT or oral quinine (6 or 
12 %, by admission diagnosis or by severe sign, respec-
tively) or did not receive any anti-malarial (2 or 6  %, 
by admission diagnosis or by severe sign, respectively) 
(Fig. 4).
Diagnosis of uncomplicated malaria
Patients without documentation of a severe sign and 
without an admission diagnosis of severe malaria were 
analysed as suspected or confirmed uncomplicated 
malaria patients (N  =  299). Among these patients, 119 
(43  %) had a laboratory confirmed diagnosis, 80 (24  %) 
had a negative laboratory test for malaria, and 100 (33 %) 
were not tested or did not have a malaria test result docu-
mented (Additional file 1).
Treatment of uncomplicated malaria patients
Overall, 26 % (95 % CI 18–35) of uncomplicated malaria 
patients were correctly treated, either with an ACT or 
oral quinine exclusively (80  %) or no anti-malarial for 
patients with a negative malaria test result (20  %). Of 
the patients correctly treated with an oral anti-malarial 
exclusively, 81 % received AL, 18 % received oral quinine, 
and 2 % received both. No patients received artesunate-
amodiaquine. Half of all uncomplicated malaria patients 
(53, 95  % CI 42–64) were adequately treated with IV 
quinine alone or in combination with an ACT or oral 
quinine. A notable proportion of patients (19, 95  % CI 
12–25) were treated with one or more anti-malarials 
despite a negative test result (over-treated) and, among 
these patients, 53 % (95 % CI 41–66) received an IV anti-
malarial. Few uncomplicated malaria patients (2, 95 % CI 
0–4) were under-treated with an ineffective anti-malarial 
or no treatment (Fig. 5).
Discussion
In this nationwide health facility survey assessing inpa-
tient management of severe malaria in Malawi, malaria 
accounted for a high burden of hospital admissions (52 %) 
and most patients admitted with severe malaria were 
Patient records screened from 
October 2011 and April 2012
n = 4982




n = 2570 (51.6%)
Records abstracted
n = 1046 (44.8%)




n = 906 (78.6%)
Insufficient patient records 
per stratum*
n = 106
 8 records per stratum: n = 2 HFs  
 7 records per stratum: n = 7 HFs 
 6 records per stratum: n = 11 HFs
 5 records per stratum: n = 9 HFs 
1 to 4 records per stratum: n = 6 HFs





Fig. 2 Study profile of patient records screened and analysed. HF 
health facility. (Asterisk) Desired sample size was 1076 patient records. 
After adjustment for potential loss of 10 % due to missing data, the 
sample size was equivalent to 8 patient records per age and month 
strata. Most HFs had an insufficient number of records per strata; 
missing records were not replaced
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treated with the correct IV anti-malarial in accordance 
with national treatment guidelines (85 %). However, diag-
nostic practices for severe malaria and case management 
practices for uncomplicated malaria were not consistently 
in line with the recommendations described in the 2011 
Malawi Revised Guide for the Management of Malaria. 
Health worker recognition and/or documentation of severe 
malaria signs was found to be sub-optimal. In addition, 
the overuse of IV anti-malarial drugs for the treatment 
of uncomplicated malaria, which is not consistent with 
national guidelines, was observed in over half of uncom-
plicated malaria patients. The quality of documentation of 
patient records may have affected the results of this sur-
vey; however, the findings presented from this study reflect 
areas that can be improved in order to provide optimal care 
to malaria patients who are hospitalized for their illness.
Patient records were used to retrospectively evaluate 
severe malaria case management in this survey. Incon-
sistencies between admission diagnosis and the corre-
sponding documentation of severe signs were observed. 
A large proportion of patients (31 %) with an admission 
diagnosis of severe malaria did not have a documented 
sign of severe disease and, conversely, many patients 
(51  %) with a documented sign of severe disease were 
not diagnosed with severe malaria. Assuming that the 
patients with an admission diagnosis of severe malaria 
were accurately diagnosed, the 31  % who lacked docu-
mentation of any severe signs are most likely a result of 
poor documentation practice. Several potential reasons 
could explain the absence of an admission diagnosis of 
severe malaria in the 51 % of patients with a documented 
severe sign.
First, many of the patients had an admission diagnosis 
of unspecified malaria, which may reflect a lack of docu-
mentation that the illness was severe malaria. Second, it 
is possible that the health care worker did not recognize 
the severe sign as a sign of severe malaria and, as a result, 
did not make the corresponding diagnosis of severe 
Table 2 Health Worker diagnosis at admission, by age
p value determined by Rao–Scott Chi Square
* p < 0.05
** Includes admission diagnosis of severe malaria, cerebral malaria, or severe anemia as documented by the health worker
Admission Diagnosis <5 years ≥5 years p value
n % (95% CI) n % (95% CI)
Severe malaria* 213 45.4 (37.8–52.9) 153 32.1 (24.0–40.3) 0.0040
Cerebral malaria 1 0.3 (0.0–0.8) 3 0.4 (0.0–1.0) –
Uncomplicated malaria 10 1.5 (0.4–2.7) 14 2.9 (0.8–5.1) 0.089
Malaria (unspecified)* 209 46.3 (38.2–54.5) 240 57.8 (48.0–67.6) 0.011
Severe anaemia 11 2.2 (0.5–3.9) 6 1.1 (0.2–1.9) 0.079
Sepsis 3 0.4 (0.0–1.1) 2 0.3 (0.0–0.7) –
Pneumonia 4 0.7 (0.0–1.5) 1 0.3 (0.0–1.0) –
Gastroenteritis/Dehydration 1 0.3 (0.0–0.8) 3 0.5 (0.0–1.6) –
Other 6 1.5 (0.0–3.3) 15 3.4 (1.3–5.5) 0.13
Not documented 5 1.5 (0.1–2.9) 6 1.3 (0.1–2.4) 0.82
Severe malaria by study definition*, ** 225 47.8 (40.2–55.4) 162 33.6 (25.1–42.1) 0.0021
Table 3 Documented clinical or laboratory symptoms 
of severe malaria, by age
p value determined by Rao–Scott Chi square
* p < 0.05
Symptom <5 years ≥5 years p value
n % (95% CI) n % (95% CI)
Seizures* 118 23.8 (18.5–29.2) 51 14.2 (7.3–21.1) 0.026
Lethargy/Coma 74 15.1 (10.7–19.5) 65 15.5 (10.4–20.6) 0.91
Vomiting every‑
thing
24 4.4 (2.1–6.8) 17 3.1 (1.4–4.9) 0.39
Unable to eat* 38 7.4 (4.6–10.3) 19 5.0 (2.2–7.7) 0.18
Jaundice* 19 3.3 (1.0–5.6) 4 0.7 (0.0–1.6) 0.0059
Difficulty breath‑
ing*
61 12.3 (8.0–16.5) 24 4.4 (2.1–6.6) 0.0002
Difficulty urinat‑
ing
6 1.1 (0.0–2.4) 5 1.1 (0.1–2.2) 0.98
Red urine 3 0.5 (0.0–1.2) 2 0.6 (0.0–1.5) –
Easy bleeding/
bruising
0 0 0 0 –
Abnormal men‑
tal status
14 2.5 (1.1–3.9) 22 4.3 (1.7–6.9) 0.19
Abnormal neu‑
rologic exam
11 2.2 (1.0–3.4) 13 2.8 (1.2–4.3) 0.56
Severe anaemia* 51 9.6 (4.9–14.2) 20 3.8 (1.8–5.7) 0.0004
At least one 
severe symp‑
tom
287 56.1 (47.8–64.3) 177 42.4 (30.8–54.1) 0.06
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malaria. Finally, the severe sign could have developed 
after admission and, therefore, the admission diagnosis 
was accurate. Given the challenges with documentation, 
in this study the definitions of severe malaria diagnosis 
were analysed separately by both admission diagnosis 
and by documentation of a sign of severe disease. A 2009 
health facility study in Uganda also found poor documen-
tation of severe malaria signs, with only 28  % of severe 
malaria patient records indicating at least one severe sign 
[8]. Structured admission record forms have been shown 
to improve documentation of signs and symptoms [13] 
and, at the time of this survey, standardized admission 
forms were being introduced in many facilities in Malawi. 
More widespread implementation and use of these forms 
could improve documentation of signs as well as facilitate 
diagnoses made by health workers.
In accordance with the Malawi Revised Guide for the 
Management of Malaria (2011), severe malaria patients 
should be treated with IV quinine or IV artesunate upon 
clinical presentation of severe signs, even prior to blood 
smear confirmation, and IV treatment should be contin-
ued for parasitologically-confirmed patients. Therefore, 
any patients suspected of having severe malaria either 
by admission diagnosis or by documentation of a severe 
sign should have received a recommended IV anti-
malarial. A majority of patients in this study (93 and 
82  % by admission diagnosis and severe sign, respec-
tively) were correctly treated with an IV anti-malarial; 
a very small percent received no anti-malarial (2  % by 
admission diagnosis and 6  % by severe sign), while the 
remaining patients received exclusively oral therapy 
(ACT or quinine) (6 % by admission diagnosis and 12 % 
by severe sign). Although parasitologic confirmation 
was not required for administration of IV therapy, 51 % 
of severe malaria patients (defined by either admission 
diagnosis or presence of a severe sign) who received the 
recommended IV therapy were confirmed malaria cases, 
16 % were negative and 34 % did not have a documented 
malaria testing result. For the patients with a negative 
test result who were given IV therapy, it is possible that 
laboratory results were available after IV therapy had 
commenced and IV therapy was ceased once the nega-
tive result was determined. Of note, no patients receiv-
ing IV therapy were given artesunate. IV artesunate was 
Documented sign of 
severe malaria *
(n = 464, 50.4% overall)
Admission diagnosis 
of severe malaria **
(n = 387, 41.8% overall)
Documented sign of severe malaria 
and
admission diagnosis 
(n = 244, 24.8% overall)
Fig. 3 Patient distribution by definition of severe malaria. More than half of patients (59 %) with an admission diagnosis of severe malaria (shaded 
in blue) also had a documented sign of severe disease, while 49 % with a documented sign (shaded in red) were diagnosed with severe malaria 
at admission. Overall, 25 % of patients had severe malaria both by admission diagnosis and by documentation of a severe sign (shaded in purple). 
(Asterisk) At least one documented clinical or laboratory sign of severe malaria. (Double asterisk) Admission diagnosis of severe malaria, cerebral 
malaria, or severe anemia as documented by the healthcare worker
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included as recommended therapy for severe malaria 
in the 2011 guidelines; however, training of health care 
workers in the use of artesunate was not completed until 
2015 and artesunate was not readily available at health 
facilities during the time frame of this study (Peter Troell; 
personal communication).
The finding that significantly more severe malaria 
patients defined by admission diagnosis received cor-
rect treatment compared to patients defined by severe 
sign suggests that health workers failed to recognize that 
these severe signs indicate the need for IV therapy. This 
speculation is supported by poor recognition of signs of 
severe disease during a malaria-knowledge assessment 
of health workers interviewed at the time of the survey 
in which 43 % of health workers were not able to name 
at least three signs of severe malaria (Briggs–Hagen, M; 
unpublished data). In addition to poor health worker 
knowledge, the lack of availability of medical supplies 
or recommended IV anti-malarials could have con-
tributed to incorrect treatment. According to a health 
facility assessment conducted at the time of the survey, 
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Fig. 4 Treatment of severe malaria, by definition of severe disease and by age. ACT artemisinin‑based combination therapy; IV intravenous. Error 




















































Fig. 5 Treatment of uncomplicated malaria, by age. Error bars indicate 95 % confidence interval for the proportion correctly treated
Page 10 of 11Shah et al. Malar J  (2016) 15:369 
treatments for severe malaria within the prior 3 months 
(Briggs–Hagen, M; unpublished data). However, given 
that the treatment stock-outs are unrelated to the defi-
nitions of severe disease, the observed difference in the 
proportion of patients correctly treated by definition of 
severe disease suggests that one of the alternative expla-
nations proposed is more plausible.
Although the focus of this study was to assess the 
quality of severe malaria case management, the diagno-
sis and treatment of uncomplicated malaria patients in 
inpatient settings was also evaluated. National guidelines 
recommend that all patients suspected of uncomplicated 
malaria receive parasitological confirmation by either 
microscopy or RDT prior to treatment. In this study, one-
third of uncomplicated malaria patients were either not 
tested or did not have a malaria test result documented. 
Although presumptive diagnosis by health workers may 
account for a proportion of patients not tested, the inad-
equate availability of diagnostic supplies in Malawi pose 
a challenge to universal diagnostic testing. RDTs were 
introduced in Malawi in 2011, and the roll-out to all gov-
ernment and CHAM facilities continued until the end 
of 2012; therefore, at the time points evaluated in this 
survey, RDT use may not have been introduced in some 
facilities. At the time of the survey, RDT stock-outs in the 
prior 3 months were reported in 44 % of health facilities 
(Briggs–Hagen, M; unpublished data). In addition, only 
some facilities had the capacity for microscopic diagno-
sis, as this requires electricity, availability of microscopes 
and slides, and trained microscopists, which were not 
consistently present. Improved health worker practices 
and availability of malaria testing supplies are required to 
improve diagnosis of uncomplicated malaria.
Appropriateness of treatment for suspected or con-
firmed uncomplicated malaria was evaluated based 
on malaria testing result. Only 26  % of uncomplicated 
malaria patients were treated correctly, while overuse of 
IV quinine, although clinically effective, was observed 
in 53  % of uncomplicated malaria patients. Although 
IV treatment is recommended in patients that present 
with vomiting at admission, 61  % of uncomplicated 
malaria patients treated with IV quinine did not have 
documented vomiting at admission. In addition among 
patients who received an admission diagnosis of uncom-
plicated malaria by the health worker, 13 % were treated 
with IV quinine. The overuse of IV quinine represents an 
unnecessary cost to the health system, and may exacer-
bate shortages leading to lack of availability for treatment 
of severe malaria patients. In this study, uncomplicated 
malaria was defined as the absence of a documented 
severe sign and without an admission diagnosis of severe 
malaria. It is possible that this led to misclassification of 
some patients who were appropriately treated with IV 
therapy for a severe sign which was not documented. 
However, among the 19  % of patients who received an 
anti-malarial despite a negative malaria test result, 53 % 
received an IV anti-malarial, suggesting true over-use of 
IV anti-malarials. Health worker non-adherence to nega-
tive malaria test results has been observed in numerous 
studies [14–19]. Reasons for non-adherence to negative 
results include provider distrust in test accuracy, patient 
dissatisfaction with diagnosis, or inability to provide 
a differential diagnosis for febrile-illness [20]. Among 
uncomplicated malaria patients in this survey, few were 
under-treated. Approximately 23  % of febrile patients 
screened were ineligible for inclusion in this study 
and may have accounted for additional uncomplicated 
malaria patients that were undertreated.
This study had several limitations. In low resource set-
tings, patient medical records are often incomplete and 
data are supplemented with other sources such as inter-
views with patients and/or providers, or direct observa-
tion of consultations [21]. Given the retrospective nature 
of reviewing patient records, it was not possible to verify 
information with providers or patients in real time to 
correct inconsistencies or obtain missing information 
prior to analysis. Additionally, missing documentation 
of information such as signs, diagnoses, medications, 
and laboratory results was considered as the absence 
of these findings from the patient’s medical history and 
could have potentially led to misclassification of diag-
nosis and treatment outcomes in this study. Although 
survey tools were designed to capture treatment dose 
and regimen, these variables could not be included as 
part of correct treatment assessment due to the lack of 
documentation in patient records. Survey tools were also 
designed to capture the initiation and completion time 
of case management activities. However, time was rarely 
documented and, therefore, it was not possible to deter-
mine the sequence of case management events such as 
whether malaria testing results were received before or 
after initiation of IV therapy. Furthermore, the inclusion 
criteria for this survey restricted the analysis to suspected 
malaria patients, which limited the ability to generalize 
the study findings for all inpatient admissions.
Conclusions
Malaria accounts for a considerable burden of hospi-
tal admissions in Malawi. In this survey, a majority of 
patients diagnosed with severe malaria received the 
recommended IV therapy in accordance with national 
treatment guidelines. However, given the inconsist-
encies observed between health worker diagnosis of 
severe malaria and documentation of severe signs, 
improvements to health worker recognition of severe 
signs and documentation are necessary to improve case 
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management practices. Efforts to encourage the use of 
diagnostic supplies and recommended treatment for 
uncomplicated malaria are necessary since insufficient 
testing and over-treatment of uncomplicated malaria was 
observed. Ongoing efforts to ensure universal access to 
appropriate diagnostic supplies and treatment, further 
training to improve health worker recognition of signs of 
severe malaria, and improvements to record keeping are 
recommended.
Authors’ contributions
MBH, JC, DPM, KAL, WD, ML, JS, and DA conceived of the research question 
and participated in the development of research design; MBH, JC, AB, AC, DM, 
MPS, and DPM participated in the training of research team and supervised 
data collection; MPS, MBH, AB, and KAL contributed in the data management 
and analysis. MPS, MBH, and JG drafted the manuscript. All authors read and 
approved the final manuscript.
Author details
1 Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Dis‑
ease Control and Prevention, 1600 Clifton Road NE, Mailstop A‑06, Atlanta, 
GA 30333, USA. 2 Malaria Alert Centre, Malawi College of Medicine, Blantyre, 
Malawi. 3 National Malaria Control Programme, Malawi Ministry of Health, 




The authors declare that they have no competing interests.
Availability of data and material
The datasets during and/or analysed during the current study available from 
the corresponding author on reasonable request.
Disclaimer
The findings and conclusions presented in this report are those of the authors 
and do not necessarily reflect the official position of the US President’s Malaria 
Initiative, US Agency for International Development, or US Centers for Disease 
Control and Prevention.
Ethics approval and consent to participate
The protocol was reviewed and approved by the Malawi College of Medicine 
Research Ethics Committee (Blantyre, Malawi), National Health Sciences 
Research Ethics Committee (Lilongwe, Malawi), and US Centers for Disease 
Control and Prevention (Atlanta, GA, USA).
This study involved retrospective patient record review and no personal 
identifiers were collected; thus, individual consent was waived.
Funding
This work was supported by the US President’s Malaria Initiative, US Agency 
for International Development, under the terms of an Interagency Agreement 
with the Centers for Disease Control and Prevention (CDC) and through a 
Cooperative Agreement (Number 5 U01 CI000189) between the CDC and the 
Malaria Alert Centre, College of Medicine. The sponsor of the study had no role 
in study design, data collection, data analysis, data interpretation, or writing 
of the report. The corresponding author had full access to all of the data the 
study and had final responsibility for the decision to submit for publication.
Additional file
Additional file 1. Treatment of uncomplicated malaria, by laboratory 
testing status and age. Error bars indicate 95 % confidence interval for the 
proportion correctly treated.
Received: 25 March 2016   Accepted: 4 July 2016
References
 1. WHO. World Malaria Report. Geneva: World Health Organization; 2015.
 2. WHO. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7–131.
 3. Dondorp AM, Lee SJ, Faiz MA, Mishra S, Price R, Tjitra E, et al. The relation‑
ship between age and the manifestations of and mortality associated 
with severe malaria. Clin Infect Dis. 2008;47:151–7.
 4. Nanda NC, Rath P, Acharya J, Mishra P, Mishra SK. Falciparum malaria in 
children‑a brief report of 305 patients from rourkela, eastern India. Indian 
J Pediatr. 2011;78:475–7.
 5. Sarkar PK, Ahluwalia G, Vijayan VK, Talwar A. Critical care aspects of 
malaria. J Intensive Care Med. 2010;25:93–103.
 6. Thwing J, Eisele TP, Steketee RW. Protective efficacy of malaria case man‑
agement and intermittent preventive treatment for preventing malaria 
mortality in children: a systematic review for the Lives Saved Tool. BMC 
Public Health. 2011;11(Suppl 3):S14.
 7. Idro R, Aketch S, Gwer S, Newton CR, Maitland K. Research priorities in the 
management of severe Plasmodium falciparum malaria in children. Ann 
Trop Med Parasitol. 2006;100:95–108.
 8. Achan J, Tibenderana J, Kyabayinze D, Mawejje H, Mugizi R, Mpeka B, et al. 
Case management of severe malaria–a forgotten practice: experiences 
from health facilities in Uganda. PLoS ONE. 2011;6:e17053.
 9. Ministry of Health Malawi and Health Metrics Network. Health Informa‑
tion Systems Assessment Report. Lilongwe: Ministry of Health; 2010.
 10. Government of Malawi Ministry of Health. Revised Guide for the Manage‑
ment of Malaria. Lilongwe: National Malaria Control Programme; 2011.
 11. National Malaria Control Programme Malawi and ICF International. 
Malaria indicator survey 2012. Lilongwe, Malawi and Calverton, Maryland, 
USA; 2012.
 12. National Malaria Control Programme Community Health Sciences Unit. 
Malaria strategic plan 2011–2015. Lilongwe; 2011.
 13. Gathara D, Nyamai R, Were F, Mogoa W, Karumbi J, Kihuba E, et al. Moving 
towards routine evaluation of quality of inpatient pediatric care in Kenya. 
PLoS One. 2015;10:e0117048.
 14. Bisoffi Z, Sirima BS, Angheben A, Lodesani C, Gobbi F, Tinto H, et al. Rapid 
malaria diagnostic tests vs. clinical management of malaria in rural Bur‑
kina Faso: safety and effect on clinical decisions. A randomized trial. Trop 
Med Int Health. 2009;14:491–8.
 15. Chinkhumba J, Skarbinski J, Chilima B, Campbell C, Ewing V, San Joaquin 
M, et al. Comparative field performance and adherence to test results of 
four malaria rapid diagnostic tests among febrile patients more than five 
years of age in Blantyre, Malawi. Malar J. 2010;9:209.
 16. Mubi M, Kakoko D, Ngasala B, Premji Z, Peterson S, Bjorkman A, et al. 
Malaria diagnosis and treatment practices following introduction of 
rapid diagnostic tests in Kibaha District, Coast Region, Tanzania. Malar J. 
2013;12:293.
 17. Nyandigisi A, Memusi D, Mbithi A, Ang’wa N, Shieshia M, Muturi A, et al. 
Malaria case‑management following change of policy to universal parasi‑
tological diagnosis and targeted artemisinin‑based combination therapy 
in Kenya. PLoS One. 2011;6:e24781.
 18. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, 
et al. Rapid diagnostic tests compared with malaria microscopy for guid‑
ing outpatient treatment of febrile illness in Tanzania: randomised trial. 
BMJ. 2007;334:403.
 19. Skarbinski J, Ouma PO, Causer LM, Kariuki SK, Barnwell JW, Alaii JA, 
et al. Effect of malaria rapid diagnostic tests on the management of 
uncomplicated malaria with artemether‑lumefantrine in Kenya: a cluster 
randomized trial. Am J Trop Med Hyg. 2009;80:919–26.
 20. Chandler CI, Whitty CJ, Ansah EK. How can malaria rapid diagnostic tests 
achieve their potential? A qualitative study of a trial at health facilities in 
Ghana. Malar J. 2010;9:95.
 21. Forsberg BC, Barros FC, Victora CG. Developing countries need more 
quality assurance: how health facility surveys can contribute. Health 
Policy Plan. 1992;7:193–6.
